Acquired
Novo Nordisk (Ozempic)
Ben Gilbert
Now, it's easy for us sitting here to say something like that because there's a lot of people that don't have that kind of cash to spend on something that could potentially change their life. So there's definitely a meaningful access problem, not just the supply constraint on the Even at a highly subsidized rate from insurance, a lot of people still can't actually afford the drugs.
0
💬
0
Comments
Log in to comment.
There are no comments yet.